Berkshire Hathaway Slashes Stake in Apple, Bank of America-March 2024-www.financetom.com

Berkshire Hathaway Slashes Stake in Apple, Bank of America

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Berkshire Hathaway Slashes Stake in Apple, Bank of America

Nov 4, 2024 11:37 AM

06:58 AM EST, 11/04/2024 (MT Newswires) -- Berkshire Hathaway (BRK.A, BRK.B) said Saturday in a filing it slashed its stake in Apple ( AAPL ) to $69.9 billion during Q3, from $84.2 billion the previous quarter.

The filing also showed that the conglomerate trimmed its stake in Bank of America ( BAC ) to $31.7 billion in Q3 from $41.1 billion in Q2.

Previous page： -- ATS Brief: Closing $400 Million Senior Notes Offering Next page： Mullen Automotive Unit to Start Production of Commercial Truck Sept. 16; Shares Rise

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

-- ATS Brief: Closing $400 Million Senior Notes Offering

Aug 21, 2024

09:59 AM EDT, 08/21/2024 (MT Newswires) -- Price: 37.38, Change: +0.25, Percent Change: +0.67 ...

Mullen Automotive Unit to Start Production of Commercial Truck Sept. 16; Shares Rise

Aug 21, 2024

10:23 AM EDT, 08/21/2024 (MT Newswires) -- Mullen Automotive ( MULN ) said Wednesday its Bollinger Motors unit plans to start production of saleable units of the Bollinger B4 chassis cab commercial truck Sept. 16. Deliveries and revenue recognition of the truck will begin in October, the electric vehicle maker said. Bollinger Motors' production is in partnership with Roush Industries,...

Sesame to Offer Novo Nordisk's Wegovy 'With No Retail Markup'

Aug 21, 2024

10:34 AM EDT, 08/21/2024 (MT Newswires) -- Healthcare marketplace Sesame said Wednesday that it will offer compounded versions of Novo Nordisk's ( NVO ) weight-loss drug Wegovy to qualified customers for $249 per month as part of its new weight-loss program in the US. Compounded semaglutide, the active ingredient in Wegovy, will be available to eligible customers with no retail...

Lexaria Bioscience Reports Blood Sugar Reductions in Ongoing Diabetes Study; Shares Fall

Aug 21, 2024

10:34 AM EDT, 08/21/2024 (MT Newswires) -- Lexaria Bioscience ( LEXX ) shares fell 2.7% in early trading Wednesday after the company reported blood sugar reductions of up to 2.50% in its ongoing animal study on GLP-1 diabetes treatments. At 56 days, DehydraTECH-liraglutide and two DehydraTECH-CBD formulations showed the highest blood sugar reductions of 2.50%, 1.90%, and 1.53%, respectively, the...